Sacituzumab tirumotecan is under clinical development by Merck and currently in Phase II for Peritoneal Cancer.

The Georgetown Public Hospital Corporation (GPHC) in a release yesterday announced that its medical staff performed Guyana’s first neonatal peritoneal dialysis, describing it as a groundbreaking ...

INCB-123667 is under clinical development by Incyte and currently in Phase I for Peritoneal Cancer. According to GlobalData, Phase I drugs for Peritoneal Cancer have an 85% phase transition success ...

Several high-profile health systems will take the stage at JPM across Monday and Tuesday. Highlights include presentations ...

Medicine distribution halted at Kozhikode Medical College for 6 days, affecting over 500 dialysis patients. Patients face ...

The PhilHealth chief added that the state health insurer is set to release new packages for prescription glasses designed for ...

The Philippine Health Insurance Corporation (PhilHealth) on Friday announced a significant expansion of its benefits package ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

The Philippine Health Insurance Corporation (PhilHealth) announced today in simple ceremony held in Pasig City ...